Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00187
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Repositioning of the Anthelmintic Drug Mebendazole for the Treatment for Colon Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2013English

Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer

Oncotarget
Oncology
2017English

Use of Genome-Wide Association Studies for Cancer Research and Drug Repositioning

PLoS ONE
Multidisciplinary
2015English

Application of Artificial Intelligence for Drug Repositioning

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Mining Integrated Semantic Networks for Drug Repositioning Opportunities

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2016English

Mining Integrated Semantic Networks for Drug Repositioning Opportunities

2015English

Pharmacological Approach for Drug Repositioning Against Cardiorenal Diseases

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2017English

Mining Integrated Semantic Networks for Drug Repositioning Opportunities

2015English

Drug Repositioning: A Faster Path to Drug Discovery

Advances in Pharmacoepidemiology & Drug Safety
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy